Status:
COMPLETED
Efficacy and Safety of Continuous Infusion of Ketamine in Pediatric Intensive Care Unit (KISS Study)
Lead Sponsor:
Azienda Ospedaliera di Padova
Conditions:
Analgesia
Ketamine Toxicity
Eligibility:
All Genders
Up to 18 years
Brief Summary
This study, prospectively evaluate the efficacy and safety of ketamine administered in continuous infusion lasted more than 12 hours in children admitted to Pediatric Intensive Care Unit of Padova. Th...
Detailed Description
Ketamine is an N-Methyl-d-aspartate-receptor-antagonist commonly used over the last decades as an anesthetic and analgesic agent for procedural sedation. The use of ketamine as a prolonged infusion wa...
Eligibility Criteria
Inclusion
- pediatric intensive care unit admission
- mechanical ventilation
- ketamine infusion \> 12 hours
Exclusion
- parents refusal to participate
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04427605
Start Date
April 1 2019
End Date
September 1 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedale Università Padova
Padua, PD, Italy, 35127